randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als The Scientific and Therapeutic Rationale Off‐Label Treatments in Amyotrophic Lateral Sclerosis - Bedlack - 2025 Cancer Research UK | Randomised
Cancer Research UK Randomised trials Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis ScienceDirect randomized double blind placebo controlled trial of acetyl l carnitine for als Clinical Evidence Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical A phase 1, randomized double blind, Pharmacometabolomics applied to lowdose interleukin2 treatment in amyotrophic lateral sclerosis Alarcan 2024 Annals of the New York Academy of Sciences Wiley Online Library
Pay in 4 interest-free payments of $5.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



